EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT

被引：1

作者：

Nathan, Steven ^{[1
]}

Bradley, Sarah ^{[1
]}

Costabel, Ulrich ^{[1
]}

Albera, Carlo ^{[1
]}

Behr, Juergen ^{[1
]}

Wuyts, Wim ^{[1
]}

Kirchgaessler, Klaus-Uwe ^{[1
]}

Stauffer, John ^{[1
]}

Morgenthien, Elizabeth ^{[1
]}

Yang, Ming ^{[1
]}

Limb, Susan ^{[1
]}

Noble, Paul ^{[1
]}

机构：

[1] Inova Fairfax Hosp, Annandale, VA USA

来源：

CHEST | 2018年 / 154卷 / 04期

关键词：

D O I：

10.1016/j.chest.2018.08.394

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：432A / 433A

页数：2

共 50 条

[1] Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
Nathan, Steven D.
Costabel, Ulrich
Albera, Carlo
Behr, Juergen
Wuyts, Wim A.
Kirchgaessler, Klaus-Uwe
Stauffer, John L.
Morgenthien, Elizabeth
Chou, Willis
Limb, Susan L.
Noble, Paul W.
RESPIRATORY MEDICINE, 2019, 153 : 44 - 51
[2] Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap
Costabel, Ulrich
Albera, Carlo
Kirchgaessler, Klaus-Uwe
Gilberg, Frank
Petzinger, Ute
Ruhrlandklinik, Paul Noble
CHEST, 2016, 150 (04) : 537A - 537A
[3] PIRFENIDONE IS EFFICACIOUS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) WITH MORE PRESERVED LUNG FUNCTION
Noble, P. W.
Bradford, W. Z.
Costabel, U.
Glaspole, I.
Glassberg, M. K.
Gorina, E.
Kardatzke, D.
Lancaster, L.
Lederer, D. J.
Nathan, S. D.
Pereira, C.
Spirig, D.
Swigris, J. J.
Valeyre, D.
Albera, C.
THORAX, 2015, 70 : A81 - A81
[4] The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Zurkova, Monika
Kolek, Vitezslav
Lostakova, Vladimira
Kriegova, Eva
Sterclova, Martina
Bartos, Vladimir
Doubkova, Martina
Binkova, Ilona
Svoboda, Michal
Strenkova, Jana
Plackova, Martina
Lacina, Ladislav
Rihak, Vladimir
Petrik, Frantisek
Lisa, Pavlina
Bittenglova, Radka
Tyl, Richard
Ondrejka, Gustav
Suldova, Hana
Lnenicka, Jaroslav
Psikalova, Jana
Snizek, Tomas
Homolka, Jiri
Kralova, Renata
Kervitzer, Jan
Vasakova, Martina
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[5] Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
Costabel, Ulrich
Albera, Carlo
Glassberg, Marilyn K.
Lancaster, Lisa H.
Wuyts, Wim A.
Petzinger, Ute
Gilberg, Frank
Kirchgaessler, Klaus-Uwe
Noble, Paul W.
RESPIRATORY RESEARCH, 2019, 20 (1):
[6] Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
Ulrich Costabel
Carlo Albera
Marilyn K. Glassberg
Lisa H. Lancaster
Wim A. Wuyts
Ute Petzinger
Frank Gilberg
Klaus-Uwe Kirchgaessler
Paul W. Noble
Respiratory Research, 20
[7] EFFECT OF PIRFENIDONE ON BREATHLESSNESS AS MEASURED BY THE UCSD-SOBQ SCORE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) WITH MODERATE LUNG FUNCTION IMPAIRMENT
Glassberg, M. K.
Wijsenbeek, M.
Gilberg, F.
Petzinger, U.
Kirchgaessler, K. U.
Albera, C.
THORAX, 2017, 72 : A251 - A251
[8] Effect Of Pirfenidone On Breathlessness As Measured By The Ucsd-Sobq Score In Patients With Idiopathic Pulmonary Fibrosis (ipf) With Moderate Lung Function Impairment
Glassberg, M. K.
Wijsenbeek, M.
Gilberg, F.
Petzinger, U.
Kirchgassler, K. -U.
Albera, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[9] Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Albera, Carlo
Costabel, Ulrich
Fagan, Elizabeth A.
Glassberg, Marilyn K.
Gorina, Eduard
Lancaster, Lisa
Lederer, David J.
Nathan, Steven D.
Spirig, Dominique
Swigris, Jeff J.
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 843 - 851
[10] Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Noble, Paul
Albera, Carlo
Kirchgaessler, Klaus-Uwe
Gilberg, Frank
Petzinger, Ute
Costabel, Ulrich
EUROPEAN RESPIRATORY JOURNAL, 2016, 48

← 1 2 3 4 5 →